Skip to main content

Displaying 433 - 444 of 2436

All Star Charts Premium,
2 to 100 Club

2 to 100 Club (01-31-2024)

January 31, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point...

GSK Reports $16.5 Million of WVE Purchases

January 31, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by GSK plc.

The British multinational pharmaceutical company reported a purchase of $16.5 million in Wave Life Sciences Ltd $WVE.

Cathie Wood's ARK Is Loading Biotech Stocks

January 30, 2024

From the Desk of Steve Strazza and Alfonso Depablos

Cathie Wood’s ARK Investment Management is on our list today, as it just filed multiple 13G filings on the following stocks:

  • Teladoc Health, Inc $TDOC, increasing its ownership stake from 11.43% to 12.82%;
  • Intellia Therapeutics, Inc $NTLA, increasing its ownership stake from 10.52% to 12.74%;
  • Recursion Pharmaceuticals, Inc $RXRX, initiating a 9.92% stake;
  • Verve Therapeutics, Inc $VERV, increasing its ownership stake from 5.43% to 8.84%;
  • Ginkgo Bioworks Holdings, Inc $DNA, increasing its ownership stake from 8.92% to 12.26%; and
  • Twist Bioscience Corp $TWST, increasing its ownership stake from 11.60% to 12.51%.
All Star Charts Premium

The Minor Leaguers (01-29-2024)

January 29, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The Minor Leaguers.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.

And it doesn't have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.

The same price and liquidity filters are applied. Then, as always, we sort by proximity to new highs in order to...

CEO Sabo Reports a $2 Million CODI Purchase

January 29, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Elias Sabo, director and CEO of Compass Group Diversified Holdings LLC $CODI.

Sabo reported an aggregate CODI purchase worth roughly $2 million.

All Star Charts Premium

The Hall of Famers (01-26-2024)

January 26, 2024

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

*Click table to enlarge view

We filter out any laggards that are down -5% or more relative to the S&P 500 over the trailing month.

Then, we sort the remaining names by their proximity to new 52-week highs.

This leaves us...

All Star Charts Premium

Junior International Hall of Famers (01-25-2024)

January 26, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The Junior International Hall of Famers.

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US-listed international stocks, or ADRs.

This scan is composed of the next 100 largest stocks by market cap, those that come after the top 100 and are thus covered by the International Hall of Famers universe.

Many of these names will someday graduate and join our original International Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

Let's dive right in and check out what these future big boys are up to.

This is our Junior International Hall of Famers list:

Click table to enlarge view

All Star Charts Premium

The Short Report (01-24-2024)

January 24, 2024

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club.

We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week, via multiple reports.

Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

We...